OPINION
NEWS
REGIONS
WORLD
BUSINESS
SPORTS
ENTERTAINMENT
LIFESTYLE
THE SUNDAY TIMES
SPECIAL FEATURES
SPECIAL SECTIONS
TMT NEWSWIRE
FAST TIMES
LEGAL ADVICE
CAMPUS PRESS
VIDEOS
EXPATS & DIPLOMATS
PHOTOS
BUSINESS FORUM
PODCASTS
RESOURCES
WEATHER
MARKET OVERVIEW
EXAM RESULTS
TMT CSI
TMT DIGITAL EDITION
GAMES
TMT 125TH ANNIVERSARY
QUIZZES
TMT Newswire > GlobeNewswire
Climb Bio to Present at William Blair's Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19
by GlobeNewswire
Oct 04, 2024 7:03 pm

WELLESLEY, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), announced today it will present and host investor meetings at William Blair's Transforming Autoimmune Diseases by Targeting CD19 event being held in New York, NY on Wednesday, October 16, 2024.

About Climb Bio, Inc.

Register to unlock this article

Register to read this story and more for free.

Signing up for an account helps us improve your browsing experience.

Continue

OR

See our subscription options.

Already have an account? Log in here

Related Articles

CMO Council Names Daniel Ng to New Role as Advisory Board President and Regional Relationship Officer in Asia

Disclosure of Voting Rights in IDEX Biometrics to Chair, Morten Opstad - 06 Oct 2024

Discover the ALITA (ALITA GOLD) Listing on XT Exchange

Discover the AEC Listing on XT Exchange

Global Aerospace's SM4 Aviation Safety Program on the Factors Influencing the Advancement of Mental Health in Aviation

Global Consulting Firm Targets Expansion After Securing Major Norwegian Investment

Sabin Vaccine Institute Delivers Marburg Vaccines to Combat Outbreak in Rwanda